RSS

Bill & Melinda Gate Foundation

Novartis has formed an alliance with the Bill & Melinda Gates Foundation to further develop its drug candidate, KDU731, for the treatment of cryptosporidiosis — a cause of infectious diarrhoea in children. more

News

Drug resistance in HIV is rising to more than 10% in people with HIV who are preparing to start (or re-start) first-line antiretroviral therapy, according to a recently published meta-analysis. more

News

T-cell receptor (TCR) company, Immunocore, has announced it will receive $40 million investment from the Bill & Melinda Gates Foundation to accelerate development of its TCR-based therapeutics for infectious diseases. more

News

With €134M ($140M) backing from the Bill & Melinda Gates Foundation, Intarcia Therapeutics is to develop its Medici drug delivery system that will reduce dosing frequency for HIV prevention medication. more

News